FindTrial
Sign In

Evaluate the effectiveness of Traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)

Evaluate the effectiveness of Traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029896
Enrollment
Unknown
Registered
2020-02-16
Start date
2020-01-31
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia

Interventions

Case series:Prescription based on syndrome differentiation of TCM and Routine treatment of Western Medicine

Sponsors

Affiliated Hospital of Changchun University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Suspected, mild, normal and severe cases diagnosed in accordance with the diagnosis and treatment scheme for pneumonia of novel coronavirus infection (trial version 5); 2. The expert team of consultation in our hospital will participate in the diagnosis and treatment.

Exclusion criteria

Exclusion criteria: 1. Unable to receive traditional Chinese medicine treatment. 2. Cases where complete diagnosis and treatment information is not available.

Design outcomes

Primary

MeasureTime frame
Conversion rate of mild and common type patients to severe type;Mortality Rate;—

Secondary

MeasureTime frame
Time for clinical symptom to disappear;Cure rate of clinical symptoms;Imaging absorption of pneumonia;The incidence of complications;Intensive Care Time;Inhospital time;Total cost of treatment;—

Countries

China

Contacts

Public ContactWang Tan

Affiliated Hospital of Changchun University of traditional Chinese Medicine

Wangtan215@sina.com+86 13756858523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026